Last reviewed · How we verify

NCT03826420

Swift, Certain, and Fair: Reducing Recidivism and Improving Outcomes for Alcohol and Drug Users on State Parole

Status unknown NA Last updated 11 March 2019
What this trial tests

NA trial testing SCF Supervision with Secure Confinement Sanctioning in Substance Abuse in 250 participants. Status unknown.

Timeline
1 April 2019
Primary endpoint
15 August 2020
31 December 2020

Quick facts

Lead sponsorBotec Analysis, LLC
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeprevention
Enrollment250
Start date1 April 2019
Primary completion15 August 2020
Estimated completion31 December 2020

Drugs / interventions tested

Conditions studied

Sponsor

Botec Analysis, LLC

Who can join

18 and older, male only, with Substance Abuse or Criminal Behavior. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This research project will study the outcomes of medium- to high-risk parolees with a history of substance abuse in Alleghany County, Pennsylvania supervised under Swift-Certain-Fair parole. The research goals are to: * Determine the effectiveness of SCF parole in reducing recidivism among medium- to high-risk parolees with a history of substance abuse in Pennsylvania. * Determine the minimum effective sanction in response to a violation that will bring parolees into compliance with the conditions of their parole.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Substance Abuse

Currently open trials in the same condition.

Other Botec Analysis, LLC trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03826420.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing